These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 26567912)
41. miR-503-3p promotes epithelial-mesenchymal transition in breast cancer by directly targeting SMAD2 and E-cadherin. Zhao Z; Fan X; Jiang L; Xu Z; Xue L; Zhan Q; Song Y J Genet Genomics; 2017 Feb; 44(2):75-84. PubMed ID: 28161325 [TBL] [Abstract][Full Text] [Related]
42. miR-671-5p inhibits epithelial-to-mesenchymal transition by downregulating FOXM1 expression in breast cancer. Tan X; Fu Y; Chen L; Lee W; Lai Y; Rezaei K; Tabbara S; Latham P; Teal CB; Man YG; Siegel RS; Brem RF; Fu SW Oncotarget; 2016 Jan; 7(1):293-307. PubMed ID: 26588055 [TBL] [Abstract][Full Text] [Related]
43. miR-375 inhibits the invasion and metastasis of colorectal cancer via targeting SP1 and regulating EMT-associated genes. Cui F; Wang S; Lao I; Zhou C; Kong H; Bayaxi N; Li J; Chen Q; Zhu T; Zhu H Oncol Rep; 2016 Jul; 36(1):487-93. PubMed ID: 27222350 [TBL] [Abstract][Full Text] [Related]
44. miR-137 suppresses the invasion and procedure of EMT of human breast cancer cell line MCF-7 through targeting CtBP1. Han Y; Bi Y; Bi H; Diao C; Zhang G; Cheng K; Yang Z Hum Cell; 2016 Jan; 29(1):30-6. PubMed ID: 26337822 [TBL] [Abstract][Full Text] [Related]
45. Down-Regulation of miR-194-5p for Predicting Metastasis in Breast Cancer Cells. Yen YT; Yang JC; Chang JB; Tsai SC Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008751 [TBL] [Abstract][Full Text] [Related]
46. miR-190 suppresses breast cancer metastasis by regulation of TGF-β-induced epithelial-mesenchymal transition. Yu Y; Luo W; Yang ZJ; Chi JR; Li YR; Ding Y; Ge J; Wang X; Cao XC Mol Cancer; 2018 Mar; 17(1):70. PubMed ID: 29510731 [TBL] [Abstract][Full Text] [Related]
47. MicroRNA-9 is associated with epithelial-mesenchymal transition, breast cancer stem cell phenotype, and tumor progression in breast cancer. Gwak JM; Kim HJ; Kim EJ; Chung YR; Yun S; Seo AN; Lee HJ; Park SY Breast Cancer Res Treat; 2014 Aug; 147(1):39-49. PubMed ID: 25086633 [TBL] [Abstract][Full Text] [Related]
48. PIK3R1 targeting by miR-21 suppresses tumor cell migration and invasion by reducing PI3K/AKT signaling and reversing EMT, and predicts clinical outcome of breast cancer. Yan LX; Liu YH; Xiang JW; Wu QN; Xu LB; Luo XL; Zhu XL; Liu C; Xu FP; Luo DL; Mei P; Xu J; Zhang KP; Chen J Int J Oncol; 2016 Feb; 48(2):471-84. PubMed ID: 26676464 [TBL] [Abstract][Full Text] [Related]
49. Restin suppressed epithelial-mesenchymal transition and tumor metastasis in breast cancer cells through upregulating mir-200a/b expression via association with p73. Lu Z; Jiao D; Qiao J; Yang S; Yan M; Cui S; Liu Z Mol Cancer; 2015 May; 14():102. PubMed ID: 25972084 [TBL] [Abstract][Full Text] [Related]
50. Estrogen receptor beta as epigenetic mediator of miR-10b and miR-145 in mammary cancer. Piperigkou Z; Franchi M; Götte M; Karamanos NK Matrix Biol; 2017 Dec; 64():94-111. PubMed ID: 28797712 [TBL] [Abstract][Full Text] [Related]
51. miR-143 suppresses epithelial-mesenchymal transition and inhibits tumor growth of breast cancer through down-regulation of ERK5. Zhai L; Ma C; Li W; Yang S; Liu Z Mol Carcinog; 2016 Dec; 55(12):1990-2000. PubMed ID: 26618772 [TBL] [Abstract][Full Text] [Related]
52. microRNA-145 modulates epithelial-mesenchymal transition and suppresses proliferation, migration and invasion by targeting SIP1 in human cervical cancer cells. Sathyanarayanan A; Chandrasekaran KS; Karunagaran D Cell Oncol (Dordr); 2017 Apr; 40(2):119-131. PubMed ID: 27933466 [TBL] [Abstract][Full Text] [Related]
54. Loss of the polycomb protein Mel-18 enhances the epithelial-mesenchymal transition by ZEB1 and ZEB2 expression through the downregulation of miR-205 in breast cancer. Lee JY; Park MK; Park JH; Lee HJ; Shin DH; Kang Y; Lee CH; Kong G Oncogene; 2014 Mar; 33(10):1325-35. PubMed ID: 23474752 [TBL] [Abstract][Full Text] [Related]
55. MiR-92b inhibited cells EMT by targeting Gabra3 and predicted prognosis of triple negative breast cancer patients. Li YY; Zheng XH; Deng AP; Wang Y; Liu J; Zhou Q; Cheng GY; Jiang Q Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10433-10442. PubMed ID: 31841197 [TBL] [Abstract][Full Text] [Related]
56. TIP60-miR-22 axis as a prognostic marker of breast cancer progression. Pandey AK; Zhang Y; Zhang S; Li Y; Tucker-Kellogg G; Yang H; Jha S Oncotarget; 2015 Dec; 6(38):41290-306. PubMed ID: 26512777 [TBL] [Abstract][Full Text] [Related]
57. miR-300 regulates the epithelial-mesenchymal transition and invasion of hepatocellular carcinoma by targeting the FAK/PI3K/AKT signaling pathway. Wang R; Yu Z; Chen F; Xu H; Shen S; Chen W; Chen L; Su Q; Zhang L; Bi J; Zeng W; Li W; Huang X; Wang Q Biomed Pharmacother; 2018 Jul; 103():1632-1642. PubMed ID: 29864952 [TBL] [Abstract][Full Text] [Related]
58. MiR-206 suppresses epithelial mesenchymal transition by targeting TGF-β signaling in estrogen receptor positive breast cancer cells. Yin K; Yin W; Wang Y; Zhou L; Liu Y; Yang G; Wang J; Lu J Oncotarget; 2016 Apr; 7(17):24537-48. PubMed ID: 27014911 [TBL] [Abstract][Full Text] [Related]
59. miR-184 Inhibits Tumor Invasion, Migration and Metastasis in Nasopharyngeal Carcinoma by Targeting Notch2. Zhu HM; Jiang XS; Li HZ; Qian LX; Du MY; Lu ZW; Wu J; Tian XK; Fei Q; He X; Yin L Cell Physiol Biochem; 2018; 49(4):1564-1576. PubMed ID: 30223264 [TBL] [Abstract][Full Text] [Related]
60. Autoregulation of phospholipase D activity is coupled to selective induction of phospholipase D1 expression to promote invasion of breast cancer cells. Kang DW; Park MH; Lee YJ; Kim HS; Lindsley CW; Alex Brown H; Min do S Int J Cancer; 2011 Feb; 128(4):805-16. PubMed ID: 20473892 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]